Erin Kenny, MSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 695 President Pl Ste 202, Smyrna, TN 37167 Phone: 615-269-4990 Fax: 615-953-9862 |
Landra Marks Orr, LCSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 98 Mayfield Dr Ste C, Smyrna, TN 37167 Phone: 615-319-3943 Fax: 615-461-8413 |
Latierra Rowland, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 6612 Hanworth Trce, Smyrna, TN 37167 Phone: 919-741-2589 |
Ms. Elise F. Waring-vincent, LCSW Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 617 Potomac Pl, Suite 401, Smyrna, TN 37167 Phone: 615-267-0779 Fax: 615-625-3371 |
Jamie Lynn Langley, LCSW, RPT-S Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 617 Potomac Pl Ste 401, Smyrna, TN 37167 Phone: 615-267-0779 Fax: 615-625-3371 |
Kate N Sjostrom, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 617 Potomac Pl Ste 403, Smyrna, TN 37167 Phone: 615-667-0037 Fax: 615-331-5649 |
Dr. April Etoye Stewart, PH.D., LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1658 Lee Victory Pkwy Unit 645, Smyrna, TN 37167 Phone: 615-423-7468 |
Mrs. Alesha Nicole Martin, L.C.S.W. Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 10543 Cedar Grove Rd, Suite 130, Smyrna, TN 37167 Phone: 615-768-9295 |
News Archive
CEA-Leti and CLARA today announced the development of a new fluorescence-imaging agent that could significantly increase surgeons' accuracy when removing cancerous tumors.
Celsis In Vitro, Inc. announced today that it has filed a patent infringement lawsuit against XenoTech LLC, Sekisui Chemical Co. Ltd., and Sekisui Medical Co. Ltd. in the United States District Court for the Northern District of Illinois in Chicago. XenoTech and Sekisui Medical are wholly-owned subsidiaries of Sekisui Chemical.
Pro-Pharmaceuticals, Inc., the leading developer of therapeutics that target Galectin proteins to treat cancer and fibrosis, today announced that the Japan Patent Office has accepted a new patent, No. 2002-574987, "Co-administration of a Polysaccharide with a Chemotherapy for the Treatment of Cancer". The patent protects, among other things, methods for reducing the toxicity of chemotherapies in which a polysaccharide, such as the Company's lead drug DAVANATĀ®, is co-administered with a chemotherapeutic agent to reduce toxicity of the chemotherapy.
Howard Hughes Medical Institute (HHMI) researchers have deciphered a key part of the regulatory code that governs how motor neurons in the spinal cord connect to specific target muscles in the limbs.
› Verified 2 days ago